Newsletter Subject

Get in before FDA approval for 1,000% gains

From

theconservativeinvestordaily-mail.com

Email Address

mailer@theconservativeinvestordaily-mail.com

Sent On

Mon, Jun 8, 2020 12:03 PM

Email Preheader Text

If you do not want to receive emails from us, you can The Latest From The Conservative Investor Dail

If you do not want to receive emails from us, you can [follow this link to unsubscribe.]( The Latest From The Conservative Investor Daily [The Conservative Investor Daily] Dear Friend, Imagine grabbing your smartphone tomorrow morning... And before you check your email or read the headlines, you hold your phone to your eye for a quick scan. Within seconds, [you're told the exact state of your health](. It will detect if you're infected with the latest scary virus, or the common cold...long before you notice a fever. Your morning scan can catch tiny changes to a cell is the beginning of cancer...years before you notice a single symptom. Or spot an undetectable tremor in your eye that’s an early warning sign of Parkinson's. Sounds like science fiction, right? But it's much closer than you think. This innovative technology is being tested as we speak and has just received the FDA's rare "Breakout Device Designation." This means it's been fast-tracked for approval. So the company behind it gets to cut through the normal red tape and get this powerful breakthrough to market faster. Very soon this breakout technology will be on every smartphone, tablet, laptop and desktop. [I have the name of the little-known $4 stock behind this breakthrough.]( you'll want to know it, too—before that FDA approval comes through. Because I have seen stocks rise 1,000% or close to it in a single day with FDA approval. And I think that's just the beginning. Because this stock belongs to an elite group of stocks called "disruptors" that have seen historic gains of 2,694%, 15,295%, 34,340%...even 130,376%. I'll explain everything in a brand-new report I've just released. [Just click here to read it now.]( You'll get the exciting details about this breakout technology poised for FDA approval any day now...and how you can get into this $4 stock before the huge price runup begins. But you must act quickly. [Get the details now.]( Sincerely, [Stephen McBride] Stephen McBride Chief Analyst, RiskHedge [View this email in your browser]( This Email is From Our Associates At RiskHedge You are receiving this e-mail at {EMAIL} as a part of your free subscription to The Conservative Investor Daily E-Letter. To read our privacy policy [follow this link.]( Or If you do not want to receive emails from us, you can [follow this link to unsubscribe.]( To unsubscribe by mail, write us at: The Conservative Investor Daily | Attn: Darwin List Network | 2319 N Andrews Avenue Fort Lauderdale, FL 33311: 1-800-496-9838 Website: [The Conservative Investor Daily]( Advertising Disclosure: This email contains paid advertisements. Nothing in this email should be considered personalized financial advice. Staff members at The Conservative Investor Daily are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright © 2018 [The Conservative Investor Daily](. All rights reserved. [-]( The Conservative Investor Daily, 26278 N. Federal Hwy. Suite 424, Fort Lauderdale, FL 33309, United States You may [unsubscribe]( or [change your contact details]( at any time.

Marketing emails from theconservativeinvestordaily-mail.com

View More
Sent On

07/10/2021

Sent On

07/10/2021

Sent On

06/10/2021

Sent On

06/10/2021

Sent On

05/10/2021

Sent On

05/10/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.